282 related articles for article (PubMed ID: 16204272)
1. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
[TBL] [Abstract][Full Text] [Related]
2. Blunted renal dopaminergic system activity in HgCl2-induced membranous nephropathy.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Life Sci; 2006 Feb; 78(11):1246-55. PubMed ID: 16182313
[TBL] [Abstract][Full Text] [Related]
3. Jejunal dopamine and Na,K+-ATPase activity in nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Am J Nephrol; 2005; 25(4):382-92. PubMed ID: 16088079
[TBL] [Abstract][Full Text] [Related]
4. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
Kikuchi M; Fujimoto S; Fukae H; Kinoshita H; Kita T; Nakazato M; Eto T
J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
[TBL] [Abstract][Full Text] [Related]
5. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
Keeler R
Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
[TBL] [Abstract][Full Text] [Related]
6. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.
Audigé A; Yu ZR; Frey BM; Uehlinger DE; Frey FJ; Vogt B
Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
9. Effects of uroguanylin on natriuresis in experimental nephrotic rats.
Baba A; Fujimoto S; Kikuchi M; Kita T; Kitamura K
Nephrology (Carlton); 2009 Feb; 14(1):80-5. PubMed ID: 19054333
[TBL] [Abstract][Full Text] [Related]
10. Renal dopaminergic system activity in rat remnant kidney up to twenty-six weeks after surgery.
Moreira-Rodrigues M; Sampaio-Maia B; Pestana M
Life Sci; 2009 Mar; 84(13-14):409-14. PubMed ID: 19167406
[TBL] [Abstract][Full Text] [Related]
11. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes.
Deschênes G; Doucet A
J Am Soc Nephrol; 2000 Apr; 11(4):604-615. PubMed ID: 10752519
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome.
Besse-Eschmann V; Klisic J; Nief V; Le Hir M; Kaissling B; Ambühl PM
J Am Soc Nephrol; 2002 Sep; 13(9):2199-206. PubMed ID: 12191963
[TBL] [Abstract][Full Text] [Related]
13. [Role of tubular Na-K-ATPase in nephrotic syndrome induced by puromycin in the rat].
Féraille E
Nephrologie; 1994; 15(4):301-5. PubMed ID: 7984251
[TBL] [Abstract][Full Text] [Related]
14. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
15. Hyperaldosteronemia and activation of the epithelial sodium channel are not required for sodium retention in puromycin-induced nephrosis.
Lourdel S; Loffing J; Favre G; Paulais M; Nissant A; Fakitsas P; Créminon C; Féraille E; Verrey F; Teulon J; Doucet A; Deschênes G
J Am Soc Nephrol; 2005 Dec; 16(12):3642-50. PubMed ID: 16267158
[TBL] [Abstract][Full Text] [Related]
16. Jejunal dopamine and Na,K-ATPase activity in early chronic renal insufficiency.
Sampaio-Maia B; Serrao P; Moura M; Pestana M
Nephrology (Carlton); 2006 Feb; 11(1):63-7. PubMed ID: 16509935
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
[TBL] [Abstract][Full Text] [Related]
19. Na(+)-K(+)-ATPase activity: role in the impaired sodium excretion of experimental nephrosis in rats.
Lu SG; Jiang XY; Hu MC; Guo M
Chin Med J (Engl); 1994 Jul; 107(7):536-40. PubMed ID: 7956502
[TBL] [Abstract][Full Text] [Related]
20. Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome.
Fernandes-Cerqueira C; Sampaio-Maia B; Quelhas-Santos J; Moreira-Rodrigues M; Simões-Silva L; Blazquez-Medela AM; Martinez-Salgado C; Lopez-Novoa JM; Pestana M
Biomed Res Int; 2013; 2013():397391. PubMed ID: 23956981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
